X
https://www.prnewswire.com/news-releases/aucta-announces-fda-approval-of-a-generic-version-of-perforomist-formoterol-fumarate-inhalation-solution-301691187.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215332
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216486
https://www.prnewswire.com/news-releases/aucta-pharma-and-oakrum-pharma-announce-launch-of-generic-version-of-jadenur-sprinkle-deferasirox-granules-301310888.html
https://www.prnewswire.com/news-releases/oakrum-pharma-and-aucta-pharma-announce-us-fda-approval-of-generic-version-of-jadenu-sprinkle-deferasirox-granules-301252585.html
https://www.biospace.com/article/fda-action-alert-eton-pharmaceuticals-and-vertex-pharmaceuticals/
https://www.ptcommunity.com/wire/oakrum-pharma-announces-launch-pyrimethamine-25mg-tablets-united-states
https://www.nasdaq.com/articles/fda-says-no-to-epilepsy-drug-imv-advances-covid-19-vaccine-isee-delays-study-2020-03-19
https://www.contractpharma.com/contents/view_breaking-news/2019-08-29/eton-receives-nda-acceptance-for-oral-liquid-seizure-medication/
https://www.globenewswire.com/news-release/2019/08/06/1897895/0/en/Eton-Announces-Second-Quarter-Financial-Results-and-Highlights-Business-Progress.html
Market Place
Share 
